Does the media prefer CHE or WST?

In the previous week, West Pharmaceutical Services had 4 more articles in the media than Chemed. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 7 mentions for Chemed. West Pharmaceutical Services' average media sentiment score of 0.89 beat Chemed's score of 0.86 indicating that West Pharmaceutical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive West Pharmaceutical Services 5 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to WST or EHC?

In the previous week, West Pharmaceutical Services had 5 more articles in the media than Encompass Health. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 6 mentions for Encompass Health. West Pharmaceutical Services' average media sentiment score of 0.89 beat Encompass Health's score of 0.84 indicating that West Pharmaceutical Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 5 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Encompass Health 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer WST or COO?

In the previous week, Cooper Companies had 1 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 12 mentions for Cooper Companies and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 0.89 beat Cooper Companies' score of 0.84 indicating that West Pharmaceutical Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 5 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cooper Companies 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to WST or ALGN?

In the previous week, West Pharmaceutical Services had 1 more articles in the media than Align Technology. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 10 mentions for Align Technology. Align Technology's average media sentiment score of 0.96 beat West Pharmaceutical Services' score of 0.89 indicating that Align Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 5 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 3 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer WST or MMSI?

In the previous week, West Pharmaceutical Services had 9 more articles in the media than Merit Medical Systems. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 2 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.25 beat West Pharmaceutical Services' score of 0.89 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 5 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

West Pharmaceutical Services (WST) Competitors

$359.68 +5.97 (+1.69%)

Closing price 03:59 PM Eastern

Extended Trading

$359.67 -0.01 (0.00%)

As of 06:18 PM Eastern

Compare

WST vs. CHE, EHC, COO, ALGN, and MMSI

Should you buy West Pharmaceutical Services stock or one of its competitors? MarketBeat compares West Pharmaceutical Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with West Pharmaceutical Services include Chemed (CHE), Encompass Health (EHC), Cooper Companies (COO), Align Technology (ALGN), and Merit Medical Systems (MMSI). These companies are all part of the "medical" sector.

How does West Pharmaceutical Services compare to Chemed?

Chemed (NYSE:CHE) and West Pharmaceutical Services (NYSE:WST) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk, analyst recommendations and media sentiment.

Chemed has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.16, suggesting that its stock price is 16% more volatile than the broader market.

West Pharmaceutical Services has a net margin of 16.85% compared to Chemed's net margin of 10.23%. Chemed's return on equity of 27.18% beat West Pharmaceutical Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.23%	27.18%	17.38%
West Pharmaceutical Services	16.85%	19.03%	14.06%

In the previous week, West Pharmaceutical Services had 4 more articles in the media than Chemed. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 7 mentions for Chemed. West Pharmaceutical Services' average media sentiment score of 0.89 beat Chemed's score of 0.86 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
West Pharmaceutical Services	5 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Chemed pays an annual dividend of $2.40 per share and has a dividend yield of 0.5%. West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.2%. Chemed pays out 13.1% of its earnings in the form of a dividend. West Pharmaceutical Services pays out 11.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has increased its dividend for 16 consecutive years. Chemed is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Chemed currently has a consensus price target of $480.25, indicating a potential downside of 2.59%. West Pharmaceutical Services has a consensus price target of $363.17, indicating a potential upside of 0.97%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts plainly believe West Pharmaceutical Services is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00

West Pharmaceutical Services has higher revenue and earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.59	$265.24M	$18.35	26.87
West Pharmaceutical Services	$3.07B	8.27	$493.70M	$7.48	48.09

95.9% of Chemed shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 3.3% of Chemed shares are owned by company insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

West Pharmaceutical Services beats Chemed on 13 of the 20 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Encompass Health?

West Pharmaceutical Services (NYSE:WST) and Encompass Health (NYSE:EHC) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.2%. Encompass Health pays an annual dividend of $0.76 per share and has a dividend yield of 0.7%. West Pharmaceutical Services pays out 11.8% of its earnings in the form of a dividend. Encompass Health pays out 12.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Encompass Health has increased its dividend for 2 consecutive years. Encompass Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Encompass Health has higher revenue and earnings than West Pharmaceutical Services. Encompass Health is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	8.27	$493.70M	$7.48	48.09
Encompass Health	$5.94B	1.84	$566.20M	$5.99	18.37

West Pharmaceutical Services presently has a consensus price target of $363.17, suggesting a potential upside of 0.97%. Encompass Health has a consensus price target of $143.86, suggesting a potential upside of 30.73%. Given Encompass Health's higher probable upside, analysts clearly believe Encompass Health is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00
Encompass Health	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.89

West Pharmaceutical Services has a net margin of 16.85% compared to Encompass Health's net margin of 10.04%. West Pharmaceutical Services' return on equity of 19.03% beat Encompass Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Encompass Health	10.04%	18.28%	8.27%

In the previous week, West Pharmaceutical Services had 5 more articles in the media than Encompass Health. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 6 mentions for Encompass Health. West Pharmaceutical Services' average media sentiment score of 0.89 beat Encompass Health's score of 0.84 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	5 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Encompass Health	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 97.3% of Encompass Health shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 1.8% of Encompass Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

West Pharmaceutical Services has a beta of 1.16, indicating that its stock price is 16% more volatile than the broader market. Comparatively, Encompass Health has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

Summary

West Pharmaceutical Services beats Encompass Health on 13 of the 20 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Cooper Companies?

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

West Pharmaceutical Services has a net margin of 16.85% compared to Cooper Companies' net margin of 5.57%. West Pharmaceutical Services' return on equity of 19.03% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Cooper Companies	5.57%	10.88%	7.27%

West Pharmaceutical Services has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market.

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by company insiders. Comparatively, 2.1% of Cooper Companies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

West Pharmaceutical Services currently has a consensus target price of $363.17, suggesting a potential upside of 0.97%. Cooper Companies has a consensus target price of $81.85, suggesting a potential upside of 14.76%. Given Cooper Companies' higher possible upside, analysts plainly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00
Cooper Companies	3 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.38

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	8.27	$493.70M	$7.48	48.09
Cooper Companies	$4.09B	3.40	$374.90M	$1.18	60.44

In the previous week, Cooper Companies had 1 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 12 mentions for Cooper Companies and 11 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 0.89 beat Cooper Companies' score of 0.84 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	5 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cooper Companies	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

West Pharmaceutical Services beats Cooper Companies on 12 of the 17 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Align Technology?

West Pharmaceutical Services (NYSE:WST) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

In the previous week, West Pharmaceutical Services had 1 more articles in the media than Align Technology. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 10 mentions for Align Technology. Align Technology's average media sentiment score of 0.96 beat West Pharmaceutical Services' score of 0.89 indicating that Align Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	5 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Align Technology	3 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

West Pharmaceutical Services has higher earnings, but lower revenue than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	8.27	$493.70M	$7.48	48.09
Align Technology	$4.03B	3.21	$410.35M	$5.96	30.30

West Pharmaceutical Services has a net margin of 16.85% compared to Align Technology's net margin of 10.50%. West Pharmaceutical Services' return on equity of 19.03% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Align Technology	10.50%	15.82%	10.17%

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by company insiders. Comparatively, 0.8% of Align Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

West Pharmaceutical Services has a beta of 1.16, meaning that its stock price is 16% more volatile than the broader market. Comparatively, Align Technology has a beta of 1.67, meaning that its stock price is 67% more volatile than the broader market.

West Pharmaceutical Services currently has a consensus price target of $363.17, suggesting a potential upside of 0.97%. Align Technology has a consensus price target of $206.07, suggesting a potential upside of 14.11%. Given Align Technology's higher possible upside, analysts plainly believe Align Technology is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	2.80

Summary

West Pharmaceutical Services beats Align Technology on 11 of the 16 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Merit Medical Systems?

West Pharmaceutical Services (NYSE:WST) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

West Pharmaceutical Services has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	8.27	$493.70M	$7.48	48.09
Merit Medical Systems	$1.52B	2.88	$128.49M	$2.31	31.71

West Pharmaceutical Services has a beta of 1.16, meaning that its share price is 16% more volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

In the previous week, West Pharmaceutical Services had 9 more articles in the media than Merit Medical Systems. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 2 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.25 beat West Pharmaceutical Services' score of 0.89 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	5 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

West Pharmaceutical Services presently has a consensus price target of $363.17, suggesting a potential upside of 0.97%. Merit Medical Systems has a consensus price target of $92.80, suggesting a potential upside of 26.67%. Given Merit Medical Systems' higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

West Pharmaceutical Services has a net margin of 16.85% compared to Merit Medical Systems' net margin of 9.03%. West Pharmaceutical Services' return on equity of 19.03% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Merit Medical Systems	9.03%	13.54%	7.94%

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

West Pharmaceutical Services beats Merit Medical Systems on 13 of the 17 factors compared between the two stocks.

Get West Pharmaceutical Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WST vs. The Competition

Export

Metric	West Pharmaceutical Services	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$24.99B	$16.66B	$7.06B	$23.46B
Dividend Yield	0.25%	1.32%	2.68%	4.02%
P/E Ratio	48.09	19.37	27.15	31.06
Price / Sales	8.27	2.41	526.89	19.75
Price / Cash	36.33	14.34	29.22	18.64
Price / Book	8.16	3.39	10.75	4.77
Net Income	$493.70M	$534.24M	$3.58B	$1.06B
7 Day Performance	0.55%	1.10%	-2.10%	-0.56%
1 Month Performance	9.55%	4.32%	3.32%	-0.11%
1 Year Performance	58.50%	3.43%	28.17%	16.64%

West Pharmaceutical Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WST West Pharmaceutical Services	3.0074 of 5 stars	$359.68 +1.7%	$363.17 +1.0%	+55.9%	$24.99B	$3.07B	48.09	10,800	Analyst Forecast
CHE Chemed	4.0281 of 5 stars	$479.98 -2.0%	$501.50 +4.5%	+6.1%	$6.50B	$2.53B	26.16	15,811
EHC Encompass Health	4.7504 of 5 stars	$106.98 +0.5%	$143.86 +34.5%	-7.4%	$10.56B	$5.94B	17.86	42,000	Positive News
COO Cooper Companies	2.8766 of 5 stars	$72.61 -2.1%	$81.31 +12.0%	-5.4%	$14.47B	$4.09B	61.53	15,000
ALGN Align Technology	3.7521 of 5 stars	$188.39 +2.1%	$205.85 +9.3%	-11.3%	$13.21B	$4.03B	31.61	20,290

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WST) was last updated on 7/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

West Pharmaceutical Services (WST) Competitors

WST vs. CHE, EHC, COO, ALGN, and MMSI

How does West Pharmaceutical Services compare to Chemed?

Summary

How does West Pharmaceutical Services compare to Encompass Health?

Summary

How does West Pharmaceutical Services compare to Cooper Companies?

Summary

How does West Pharmaceutical Services compare to Align Technology?

Summary

How does West Pharmaceutical Services compare to Merit Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WST vs. The Competition

West Pharmaceutical Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

West Pharmaceutical Services (WST) Competitors

WST vs. CHE, EHC, COO, ALGN, and MMSI

How does West Pharmaceutical Services compare to Chemed?

Which has more risk & volatility, CHE or WST?

Is CHE or WST more profitable?

Does the media prefer CHE or WST?

Is CHE or WST a better dividend stock?

Do analysts recommend CHE or WST?

Which has better earnings & valuation, CHE or WST?

Do insiders and institutionals have more ownership in CHE or WST?

Summary

How does West Pharmaceutical Services compare to Encompass Health?

Is WST or EHC a better dividend stock?

Which has stronger earnings and valuation, WST or EHC?

Do analysts rate WST or EHC?

Is WST or EHC more profitable?

Does the media refer more to WST or EHC?

Do institutionals and insiders hold more shares of WST or EHC?

Which has more risk & volatility, WST or EHC?

Summary

How does West Pharmaceutical Services compare to Cooper Companies?

Is WST or COO more profitable?

Which has more volatility and risk, WST or COO?

Do insiders & institutionals hold more shares of WST or COO?

Do analysts rate WST or COO?

Which has stronger earnings & valuation, WST or COO?

Does the media prefer WST or COO?

Summary

How does West Pharmaceutical Services compare to Align Technology?

Does the media refer more to WST or ALGN?

Which has stronger valuation and earnings, WST or ALGN?

Is WST or ALGN more profitable?

Do institutionals and insiders hold more shares of WST or ALGN?

Which has more volatility and risk, WST or ALGN?

Do analysts recommend WST or ALGN?

Summary

How does West Pharmaceutical Services compare to Merit Medical Systems?

Which has higher valuation & earnings, WST or MMSI?

Which has more risk and volatility, WST or MMSI?

Does the media prefer WST or MMSI?

Do analysts prefer WST or MMSI?

Is WST or MMSI more profitable?

Do institutionals and insiders hold more shares of WST or MMSI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WST vs. The Competition

West Pharmaceutical Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools